William John Sibold Madrigal Pharmaceuticals, Inc. (MDGL) insider trading activity

MDGL Quotes by TradingView

William John Sibold is President and CEO of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 104,303 shares of MDGL, which is worth approximately $36.2 Million. The most recent transaction as insider was on Feb 27, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K
86.63% 3M change
67.56% 12M change
Total Value Held $36.2 Million

William John Sibold Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2025
BUY
Exercise of conversion of derivative security
-
50,000 Added 32.4%
104,303 Common Stock
Jan 24 2025
SELL
Open market or private sale
$531,020 $335.24 p/Share
1,584 Reduced 2.83%
54,303 Common Stock
Sep 09 2024
SELL
Open market or private sale
$1,551,490 $243.83 p/Share
6,363 Reduced 10.22%
55,887 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
12,250 Added 16.44%
62,250 Common Stock
Sep 11 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 50.0%
50,000 Common Stock
WJS

William John Sibold

President and CEO
West Conshohocken, PA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MDGL